CoapTech: Funding, Investors & Team (Sep 2026)

CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world. The company seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound which is owned by the company. Its devices reduce health care costs and improve safety, quality, patient experience, and access to services around the globe. Invented by Dr. Tropello, the CoapTech delivers a novel platform technology combining magnetic attraction for device placement guidance, and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional and therapeutic procedures. Strong rare-earth magnets are used to manually guide device placement inside the human body, while real-time, low cost ultrasound provides visual feedback to the clinician to ensure safety. This platform technology, invented by the company founder, has the potential to disrupt multiple medical procedures, substantially reducing costs while improving safety and patient experience. Their lead use case, selected because of its low risk, clear FDA pathway, and strong commercial viability, is for the insertion of gastrostomy tubes. They have defined the use of Coaptive Ultrasound to perform this novel gastrostomy procedure, as Percutaneous Ultrasound Gastrostomy (PUG). Briefly, PUG is a point-of-care (as opposed to operating room) procedure for inserting gastrostomy tubes which can be quickly and easily performed by non-surgical providers. It employs readily available medical devices such as ultrasound, feeding tubes, guide-wires, and dilators.

CoapTech has raised $15.0M across 4 rounds on record. The most recent is an undisclosed round of $7.1M announced in Sep 2024.

CoapTech's most recent funding round on record is an undisclosed round of $7.1M, announced in Sep 2024.

Howard Carolan is listed as CEO at CoapTech.

CoapTech is based in Baltimore, Maryland, United States.

CoapTech is in the 11-50 employee band.

CoapTech's latest round of $7.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.